We are thrilled to announce the release of the PCOR-ANZ Annual Report 2023: “Prostate Cancer Across Australia and New Zealand PCOR-ANZ 2015-2021.” This comprehensive report is dedicated to improving clinical standards and patient outcomes in prostate cancer care through extensive data collection and analysis captured within the PCOR-ANZ registry. Update-Nov 2024:  An additional 'summary report' has now been added -see below for links. 

• see highlights below, and read full report here   or summary report here 
  
  Key Highlights Relevant to Aotearoa New Zealand:
  
  ·        Completeness of Data Collection: 100 % public cases; over 80% new diagnoses
  ·        Low access to MRI pre-biopsy and targeted biopsy techniques in Aotearoa
  ·        Higher percentage of low-risk disease diagnosed, high cost and low value
  ·        High percentage of low-risk disease managed through Active Surveillance
  
  Registry Overview:
  
  ·        The Australian and New Zealand Prostate Cancer Outcomes Registry (PCOR-ANZ) is a Movember-funded clinical registry.
  ·        Findings are based on data from 92,167 newly diagnosed individuals with prostate cancer, spanning 2015 to 2021.
  ·        Data collected from 268 clinical sites and 396 clinicians across Australia and New Zealand.
  ·        Impressive population coverage: Approximately 59% in Australia and 80% in New Zealand.
  
  Transformative Trends:
  
  Throughout the reporting period, the landscape of prostate cancer management across NCCN risk groups has undergone remarkable transformations, mirroring the strides made in international guidelines and recommendations. Two such transformative trends outlined in the report are:
  
  A shift towards Active Surveillance for Low-Risk Prostate Cancer:  Proportion of individuals opting for active surveillance increased from 66% (2015) to 80% (2021).
  Management of Prostate Cancer with Regional Involvement: Utilisation of radiation therapy alongside androgen deprivation therapy (ADT) increased from 33% (2015) to 52% (2021).
  
  These trends reflect an evolving landscape where emerging technologies and therapeutic strategies enhance patient outcomes. The PCOR-ANZ remains uniquely positioned to monitor and evaluate these care practices.
  
  

Get the Full Picture

Ready to dive into the findings? The full report and a summary version are available for download. Whether you’re a healthcare professional, researcher, or someone affected by prostate cancer, these reports provide essential information about the current state of prostate cancer care across Australia and New Zealand.

 Explore the Full Report here

Explore the Summary Report here

Acknowledgements

We extend our thanks to all the people who have participated in the PCOR-ANZ registry and contributed to this report. Your data is helping us better understand and tackle the challenges that you, and others in your position, are facing.

PCOR-ANZ also relies on the contributions of the clinical community, who work tirelessly to ensure that data is collected accurately and comprehensively. Special thanks go to the members of the PCOR-ANZ Governance Committee, the Advisory Committee, the Data Advisory Committee, the Data Coordination Centre at Monash University, and the teams of Jurisdiction Coordinators and data collectors across Australia and New Zealand.